医学
麻醉
重组因子VIIa
禁忌症
凝血病
麻醉学
硬膜外血肿
因素七
妊娠期
外科
凝结
血肿
怀孕
内科学
替代医学
病理
生物
遗传学
作者
Benjamin M. Hyers,Camila Cabrera,Christopher A. Walsh,Anusha Reddy,Talia Strulowitz,Joshua Hamburger,Nakiyah Knibbs,Daniel Katz,Lauren Ferrara,Yaakov Beilin
标识
DOI:10.1136/rapm-2024-105674
摘要
Background Factor VII deficiency is considered a contraindication to neuraxial anesthesia due to the risk of an epidural hematoma. Case Report A 32 year old G1P0 parturient with severe factor VII deficiency presented for an anesthesiology consultation at 32 weeks gestation. Initial coagulation studies were significant for an elevated INR (2.0) and a low factor VII level of 6%. After interdisciplinary discussion, it was decided that neuraxial analgesia could be offered if her coagulation studies corrected after administration of recombinant activated factor VII (rFVIIa). The patient presented at 36 weeks gestation for a rFVIIa challenge. She received 22 mcg/kg rFVIIa and coagulation studies were analyzed 20 minutes later which showed complete correction of the coagulopathy. The patient presented to the hospital at 39 weeks and 3 days for delivery, received 2 mg rFVIIa and 20 minutes later, successfully received an epidural catheter. Her INR was monitored every 3 hours during her labor course and rFVIIa was given if the INR was 1.3 or greater. She required three additional doses over 22 hours. No bleeding or thrombotic events occurred, and the patient was discharged home without complications. Conclusion This case highlights the safe management of an epidural catheter in a parturient with severe factor VII deficiency.
科研通智能强力驱动
Strongly Powered by AbleSci AI